Probiotic Ingredients Market

How Big is the Probiotic Ingredients Market in 2026?

Probiotic ingredients market value stands at USD 6.9 Billion in 2026 and will reach USD 12.7 Billion by 2036. Sales will grow at a 6.2% CAGR between 2026 and 2036.

Probiotic ingredients market size is estimated at USD 6.9 Billion in 2026, up from USD 6.5 Billion in 2025, as per FMI. Food processors, supplement brands and feed makers buy documented strains in bulk and pay for a viable count that holds through shelf life. Regulators now write that count into approvals. Indonesia's food agency cleared Kerry's BC30 for a live culture claim in February 2026, on condition of at least 1 million CFU per gram or millilitre at the end of shelf life [1].

Growth of the probiotic ingredients market will add USD 5.8 Billion between 2026 and 2036, and neighbouring biotics categories will grow faster. Sales of prebiotic ingredients will rise from USD 8.2 Billion in 2026 to USD 15.7 Billion by 2036 at a 6.7% CAGR, an opportunity of USD 7.5 Billion, often inside the same supplement and yogurt formulas.

Demand for probiotic feed supplements will create a USD 1,942.8 Million opportunity at an 8.2% CAGR, moving from USD 1,620.0 Million in 2026 to USD 3,562.8 Million by 2036. Adoption of postbiotic supplements will grow from USD 0.8 Billion to USD 2.0 Billion at 9.1%. As per FMI's analysis, live probiotic ingredients grow slower than postbiotics because each new format needs proof of cell survival, a test that inactivated cells skip.

Key Takeaways of Probiotic Ingredients Market

• Bacterial strains will hold 63.0% market share among product types in 2026.
• By end use, FMI finds that food and beverages processing will account for 70.6% of market share in 2026.
• Key companies operating in the probiotic ingredients market include Novonesis, DSM-Firmenich, Lallemand Inc., Kerry Group plc, BioGaia AB, Probi AB, International Flavors & Fragrances Inc., Archer Daniels Midland Company, Morinaga Milk Industry Co., Ltd., and Gnosis by Lesaffre, and the full report covers many more players.
• By country, Canada grows fastest at 7.5%, and Australia grows slowest at 5.2%.

Analyst Perspective

“Probiotic ingredients will move from a general gut health story to a strain-specific, evidence-led sale, with buyers asking for clinical data at the exact dose and format they plan to use. The biggest opportunity lies in heat- and shelf-stable strains for foods, beverages, gummies and animal feed, where survival through processing has long limited adoption.”

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the Probiotic Ingredients Market Segmented?

According to FMI, the probiotic ingredients market is segmented by product type, end use, end product form, and region.

Based on the product type, the market is segmented into bacterial and yeast ingredients. By end use, the report covers food and beverages processing, dietary supplements, animal feed, and personal care and cosmetics. By end product form, the study covers capsule, powder, suspension, tablet/chewable, stick pack, gel, and granule across seven regions and 27 countries and country groups.

Why Do Bacterial Strains Lead the Probiotic Ingredients Market by Product Type?

FMI finds that bacterial strains will account for 63.0% of product type in 2026.

Demand for bacterial probiotic ingredients will remain the highest by product type, as per FMI. Lactobacilli, bifidobacteria and Bacillus strains carry the deepest clinical files. Probi reports more than 300 scientific publications on LP299V alone [2]. Morinaga Milk refreshed the HRB bifidobacteria ingredient brand at Vitafoods Europe in May 2026 [3]. Yeast holds a narrower position, led by Saccharomyces strains such as the Lynside S. boulardii yeast sold by Gnosis by Lesaffre [4].

• Bacterial strains will hold 63.0% of product type revenue in 2026, backed by broad clinical files.
• In June 2026, ANVISA added three bacterial probiotics, including L. plantarum 299V and an association of two L. reuteri strains, to the authorized supplement list in Brazil [5].

Why Does Food and Beverages Processing Lead the Probiotic Ingredients Market by End Use?

At 70.6%, food and beverages processing will account for the highest market share by end use.

Food and beverage plants buy live cultures in volume for yogurts, fermented milks and juices, and each production run repeats the order. The same plants buy starter cultures, giving culture suppliers an existing account. Heat, oxygen and water activity cut counts, owing to which spore-forming strains gain ground in ambient foods. Kerry describes BC30 as a spore former that stays viable through manufacturing, storage and digestion [1].

• Food and beverages processing will lead with 70.6% of end use market share in 2026, owing to repeat culture orders.
• In February 2026, Indonesia's BPOM approved Kerry's BC30 for a live culture claim across general food categories, excluding special nutrition products [1].

Why Does Capsule Lead the Probiotic Ingredients Market by End Product Form?

Capsules will account for 25.8% of end product form in 2026, the largest share among seven formats.

Capsules give supplement brands a fixed dose and keep the culture away from moisture. Lallemand's Saint-Simon plant in France makes more than 80 million sachets a year and is adding an encapsulation line [6]. IFF offers the PureStrong canine strain in powder, capsule, tablet and stick formats [7]. Coating methods from the microencapsulation field add protection for acid-sensitive strains.

• Capsule will lead with 25.8% of end product form share in 2026, owing to measured dosing.
• In February 2026, Lallemand Health Solutions reported EUR 20 million invested at Saint-Simon over 7 years, with a new encapsulation line under way [6].

What are the Drivers, Restraints, and Opportunities in the Probiotic Ingredients Market?

As per FMI's analysis, documented strains in new food and supplement formats will drive sales, strain qualification and claim rules will slow supplier switching, and heat-stable cultures will open feed and ambient food revenue till 2036.

• Driver: Formulators place documented strains in more foods, supplements and feed products once viable counts hold through shelf life.
• Restraint: Strain identity files, end-of-shelf-life counts and country claim rules make supplier changes slow and costly.
• Opportunity: Adoption potential of heat-stable spore formers and synbiotic blends opens ambient food, pet and livestock feed contracts.

Probiotic ingredients behave differently from other functional ingredients because the active is alive, and the count falls with heat, moisture and time. Novonesis reports that Bovacillus, a Bacillus probiotic for dairy cows launched in April 2026, withstands up to 95°C, so the culture can enter pellets, premixes and mineral blocks [8]. Trials showed 1 kg more milk per cow per day and a 3.7% gain in feed efficiency [8]. As a result, strain owners with heat-stable cultures will hold feed and ambient food contracts, and buyers will requalify a strain only after a failed stability test.

Which Country CAGRs are Profiled in the Probiotic Ingredients Market?

Country	CAGR, 2026 to 2036
Canada	7.5%
UK	7.2%
Brazil	6.8%
USA	6.5%
Mexico	6.2%
Russia	5.9%
Poland	5.6%
Australia	5.2%

How do Country-level CAGRs Compare in the Probiotic Ingredients Market?

As per FMI's analysis, probiotic ingredient growth rates will differ by 2.3 percentage points across profiled countries through 2036. Canada will lead at a 7.5% CAGR, and Australia will record the slowest rate at 5.2%. The UK, Brazil and the USA also grow faster than the global 6.2% pace, and Mexico matches the global rate. A slower-growing country can still hold a larger revenue base.

• Canada leads at 7.5% on a monograph route for natural health products.
• The UK follows at 7.2%, even though the word probiotic cannot appear on pack.
• Russia at 5.9% and Poland at 5.6% sit in the lower band.
• Australia grows 2.3 points below Canada, with probiotic medicines on the TGA listed-medicine route.

Beyond the profiled countries, the full FMI report analyzes CAGRs across North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa. The study covers 27 countries and country groups.

Country Outlook

• Demand for probiotic ingredients in Canada will rise at a 7.5% CAGR, the fastest pace among profiled countries. Health Canada already runs a probiotics monograph and published a prebiotics monograph in May 2026 [9]. Industry groups are now exploring a synbiotic monograph [9]. Lallemand Health Solutions, headquartered in Mirabel, Canada, gives buyers a domestic strain supplier [10].
• Probiotic ingredients market growth in the UK will hold at a 7.2% CAGR till 2036, despite strict labelling. The term probiotic counts as an unauthorized health claim on UK packs [11]. In September 2026, the Health Food Manufacturers' Association asked the Health Secretary to allow the term, as 11 EU countries already do [11]. BioGaia launched Protectis Plus drops in May 2026, combining L. reuteri Protectis with the patented BG-R46 strain. [12].
• Sales of probiotic ingredients in Brazil will grow at a 6.8% CAGR till 2036, supported by a strain-by-strain approval list. ANVISA Normative Instruction 450 of June 2026 extended L. reuteri DSM 17938 to all population groups except pregnant and nursing women [5]. The rule sets a minimum of 100 million CFU for that strain [5]. Listed strains gain a shorter route into Brazilian supplements.
• Adoption of probiotic ingredients in the USA supports a 6.5% CAGR through 2036. At Natural Products Expo West in March 2026, Kerry presented a four-week BC30 study among GLP-1 medication users. In that study, 77% reported moderate to significant quality-of-life gains [13]. ADM sells lactic acid bacteria and spore-forming strains in bulk and finished dosage forms [14].
• Key trends in the Australian probiotic ingredients market point to compliance-led growth at a 5.2% CAGR, the lowest among profiled countries. Probiotic medicines follow the TGA listed-medicine route, so sponsors keep identity, count and stability files for each product.

Who are the Notable Companies in the Probiotic Ingredients Market?

Key companies in the market include Novonesis, DSM-Firmenich, Lallemand Inc., Kerry Group plc, BioGaia AB, Probi AB, International Flavors & Fragrances Inc., Archer Daniels Midland Company, Morinaga Milk Industry Co., Ltd., and Gnosis by Lesaffre.

Competition among probiotic ingredient suppliers centers on strain evidence, viable-count stability and regulatory reach, as per FMI. The report sorts the profiled companies into three strategy groups. BioGaia reported Q2 2026 net sales of SEK 440.9 million, up 12% excluding currency effects, with products in more than 100 markets [15]. Novonesis signed an agreement with UndoAge in June 2026 to bring stomach-health and women's-health biotics to China [16].

• Strain Platforms and Microbial Manufacturing: Novonesis, Lallemand Inc., International Flavors & Fragrances Inc. and Archer Daniels Midland Company own large strain libraries and run fermentation and drying plants.
• Biotics and Application Solution Providers: DSM-Firmenich, Kerry Group plc and Probi AB pair named strains with formulation support and clinical files.
• Proprietary Strain Specialists: BioGaia AB, Morinaga Milk Industry Co., Ltd. and Gnosis by Lesaffre build value around a few heavily studied strains.

Competitive Benchmarking

Company	Documented Strain Assets	B2B Application Breadth	Scale-Up and Formulation Support	Geographic Reach
Novonesis	High	High	High	Global
DSM-Firmenich	Medium	Medium	Medium	Europe, North America and Asia-Pacific
Lallemand Inc.	High	High	High	North America, Europe and international markets
Kerry Group plc	Medium	High	Medium	North America, Europe and Asia
BioGaia AB	High	Medium	Medium	More than 100 markets
Probi (part of Symrise Group)	High	High	Medium	EMEA, the Americas and Asia-Pacific
International Flavors & Fragrances Inc.	High	High	High	The Americas, Europe and Asia-Pacific
Archer Daniels Midland Company	High	High	High	Global
Morinaga Milk Industry Co., Ltd.	High	Medium	Medium	Japan, China and Europe
Gnosis by Lesaffre	Medium	Medium	Medium	Europe and North America

Scoring basis: Documented Strain Assets scores proprietary strains with published evidence. B2B Application Breadth scores uses supported for third-party formulators. Scale-Up and Formulation Support scores documented fermentation, drying, encapsulation and stability support. High marks broad, clearly documented capability, Medium marks narrower capability, and Low marks limited public documentation. Geographic Reach reflects evidenced sales or offices, as reviewed by FMI in September 2026.

Key Developments

• In February 2026, Kerry Group plc secured approval from Indonesia's BPOM for a live culture claim on BC30 across general food categories, with at least 1 million CFU per gram or millilitre at the end of shelf life [1].
• In April 2026, Novonesis launched Bovacillus, described as Europe's first Bacillus probiotic for dairy cows, with heat stability up to 95°C for pellets, premixes and mineral blocks [8].
• In May 2026, BioGaia AB launched Protectis Plus drops, combining the original L. reuteri Protectis strain with the new patented BG-R46 strain selected for its enhanced probiotic properties. [12].

Key Players

Strain Platforms and Microbial Manufacturing

• Novonesis
• Lallemand Inc.
• International Flavors & Fragrances Inc.
• Archer Daniels Midland Company

Biotics and Application Solution Providers

• DSM-Firmenich
• Kerry Group plc
• Probi AB

Proprietary Strain Specialists

• BioGaia AB
• Morinaga Milk Industry Co., Ltd.
• Gnosis by Lesaffre

Report Scope and Methodology

Coverage field	Report scope
Market breakdown	4 categories: Product Type (Bacterial, Yeast), End Use (Food & Beverages Processing, Dietary Supplements, Animal Feed, Personal Care & Cosmetics), End Product Form (Capsule, Powder, Suspension, Tablet/Chewable, Stick Pack, Gel, Granule), and Region
Quantitative units	USD Billion
Market definition	Revenue from probiotic bacterial and yeast cultures, strains, blends and stabilized ingredient preparations sold within the stated segmentation. The definition excludes finished consumer products, standalone prebiotics and postbiotics, adjacent substitutes and separable non-ingredient services.
Regions covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered	27 countries and country groups, with profiled CAGRs for Canada, the UK, Brazil, the USA, Mexico, Russia, Poland, and Australia
Key companies profiled	A few of the notable companies out of many players covered by FMI: Novonesis, DSM-Firmenich, Lallemand Inc., Kerry Group plc, BioGaia AB, Probi AB, International Flavors & Fragrances Inc., Archer Daniels Midland Company, Morinaga Milk Industry Co., Ltd., and Gnosis by Lesaffre
Forecast period	2026 to 2036
Approach	FMI applies a hybrid bottom-up and top-down sizing framework that reconciles strain and culture volumes, ingredient pricing and supplier revenue signals with food, supplement and feed production.

Research Methodology

Method	Approach
Primary research	FMI's primary-research framework engages strain producers, contract manufacturers, food, supplement and feed formulators, distributors and procurement teams to test strain selection, stability evidence, claim requirements, pricing and supplier switching.
Desk research	The analysis reviews regulatory decisions, health claim rules, company announcements, financial reports and product information. FMI retains sources that define strain approvals, viability requirements, supplier roles or country demand inside the market boundary.
Market sizing and forecasting	The sizing framework combines the baseline value with product type, end use and form structure, ingredient prices, culture volumes and country-level demand. Forecasts consider strain approvals, claim rules, fermentation capacity and competition from postbiotics.
Data validation	Estimates are checked against public data, company activity and interview findings. Finished consumer products, standalone prebiotics and postbiotics, and overlapping revenues are removed before final reconciliation.

Probiotic Ingredients Market by Segments

Probiotic Ingredients Market Segmented by Product Type

• Bacterial
• Yeast

Probiotic Ingredients Market Segmented by End Use

• Food & Beverages Processing
• Dietary Supplements
• Animal Feed
• Personal Care & Cosmetics

Probiotic Ingredients Market Segmented by End Product Form

• Capsule
• Powder
• Suspension
• Tablet/Chewable
• Stick Pack
• Gel
• Granule

Probiotic Ingredients Market Segmented by Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• East Asia
• South Asia and Pacific
• Middle East and Africa

Research Sources and Bibliography

• [1] Kerry Group plc (2026, February 26). BC30™ Approved for "Live Culture" Claim in Indonesia, Opening Opportunities in F&B Innovation.
• [2] Probi AB (2026, July 1). Probi celebrates 35 years of science and a new chapter with Symrise.
• [3] Nutrition Insight (2026, May 7). Vitafoods Europe 2026 live: Morinaga Milk launches new probiotics brand identity.
• [4] Gnosis by Lesaffre (2026, September). Probiotics.
• [5] Fukuma Advogados & Consultores (2026, June 12). Nova IN atualiza composição, alegações e rotulagem de suplementos alimentares.
• [6] Lallemand Health Solutions (2026, February 11). The Saint-Simon Production Plant Continues to Invest.
• [7] International Flavors & Fragrances Inc. (2026, April 2). IFF launches PureStrong™, a probiotic made specifically for dogs.
• [8] Novonesis (2026, April 29). Novonesis launches Europe's first Bacillus probiotic for dairy cows.
• [9] NutraIngredients (2026, May 1). Health Canada publishes prebiotics monograph.
• [10] Lallemand Health Solutions (2026, September 10). Lallemand Health Solutions Showcases Science-Backed Biotics Innovations at SupplySide Global 2026.
• [11] Health Food Business (2026, September 9). HFMA urges Health Minister to take action over probiotic barriers.
• [12] BioGaia AB (2026, May 7). BioGaia AB launches BioGaia® Protectis® Plus, next-generation patented probiotic drops.
• [13] Food Ingredients First (2026, March 5). Expo West 2026 live: Kerry points to flavor complexity and GLP-1 nutrition as key growth drivers.
• [14] Archer Daniels Midland Company (2026, September). Probiotics.
• [15] BioGaia AB (2026, July 17). Interim report January to June 2026.
• [16] PR Newswire (2026, June 10). UndoAge and Novonesis Forge Strategic Partnership to Drive High-Quality Development of China's Probiotic Industry.

This bibliography is provided for reader reference and is not exhaustive. The full FMI report contains the complete reference list and detailed citations.

This Report Answers

• What will the Probiotic Ingredients Market size be in 2026, and what value will FMI forecast for 2036?
• Which food, supplement and feed needs will keep supporting demand for probiotic ingredients?
• Why will bacterial strains hold the leading position within the Product Type category in 2026?
• Why will food and beverages processing lead the End Use category?
• Why will capsules lead the End Product Form category?
• How will growth rates differ across Canada, the UK, Brazil, the USA, Mexico, Russia, Poland, and Australia till 2036?
• How will end-of-shelf-life viable counts and country claim rules affect supplier switching?
• How will heat-stable and spore-forming strains open feed and ambient food uses?
• What will formulators need to check before approving a new probiotic ingredient supplier?